Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
about
RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesThe clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions.Elevated serum interleukin-35 is associated with disease activity in patients with systemic lupus erythematosus.
P2860
Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant expression of regulat ...... systemic lupus erythematosus.
@en
type
label
Aberrant expression of regulat ...... systemic lupus erythematosus.
@en
prefLabel
Aberrant expression of regulat ...... systemic lupus erythematosus.
@en
P2093
P2860
P356
P1433
P1476
Aberrant expression of regulat ...... systemic lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1177/0961203315585815
P50
P577
2015-05-11T00:00:00Z